The unified social credit code/registration number of Xidelong Tumor Drug Co., Ltd. of Fu Ren Pharmaceutical Group is 91410000947871309. Zhu Chenggong, an enterprise legal person, is currently operating.
The business scope of Fu Ren Pharmaceutical Group Xidelong Tumor Medicine Co., Ltd. is: production and sales of tablets (anti-tumor), hard capsules (anti-tumor), small-volume injections (anti-tumor) and freeze-dried powder injections (anti-tumor). (Licensed projects can only be operated after obtaining the permission of relevant departments). In Henan Province, the total registered capital of companies with similar business scope is10.85 million yuan, and the main capital is concentrated in enterprises with a scale of more than 50 million, including *** 1 1. In the province, the registered capital of enterprises is good at present.
Furen Pharmaceutical Group Xidelong Cancer Drug Co., Ltd. invested 1 company and 0 branches.
See more information and materials of Fu Ren Pharmaceutical Group Xidelong Tumor Drug Co., Ltd. through Baidu Enterprise Credit.